This hypothesis is further validated by Sun et al. who carried out a comprehensive next-generation sequencing (NSG) analysis in SCLC patients and found frequent mutations in TP53, RB1, and PTEN. These findings have strengthened the claim that Rb and TP53 could be driver genes in SCLC regardless of smoking status. This evidence concerns the gene RB1 and small cell lung carcinoma.